Albert Tauler
Founder at Uni Targeting Research AS
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Beate Stern | M | - |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | 23 years |
John E. Hesketh | M | - |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | 23 years |
Hans Johan Hekland | M | 66 |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | - |
Ian Fraser Pryme | M | 80 |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | 23 years |
María Teresa Costa Campi | M | 72 |
University of Barcelona
| 37 years |
María Isabel Trillas Gay | M | - |
University of Barcelona
| - |
Antón Costas Comesaña | M | - |
University of Barcelona
| - |
Ramón Gomis I de Barbarà | M | - |
University of Barcelona
| 13 years |
Hans-Peter Anton Knopf | M | 61 |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | - |
Antonio Esteve Cruella | M | 66 |
University of Barcelona
| 38 years |
Joan Bladé Marsal | M | 63 |
University of Barcelona
| - |
Richard Stuart Godfrey | M | 58 |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | - |
María del Carmen Fernández Rozado | M | - |
University of Barcelona
| - |
Carlota Pi Amoros | F | - |
University of Barcelona
| 20 years |
Santiago Ramon y Cajal | M | - |
University of Barcelona
| - |
Mariano Marzo Carpio | M | - |
University of Barcelona
| 35 years |
Francisco Cervantes | M | - |
University of Barcelona
| - |
Joan Francisco Corona Ramón | M | 65 |
University of Barcelona
| - |
Joan Bigorra | M | - |
University of Barcelona
| - |
Manuel José Rodríguez Allué | M | - |
University of Barcelona
| 17 years |
Salvador Alemany Más | M | 80 |
University of Barcelona
| - |
Rafael Buxó Bosch | M | - |
University of Barcelona
| - |
Carlos Franqués Ribera | M | - |
University of Barcelona
| - |
Albert Collado Armengol | M | 60 |
University of Barcelona
| - |
Martí Parellada Sabata | M | - |
University of Barcelona
| - |
Joan Hortalá i Arau | M | - |
University of Barcelona
| - |
José María Suñé | M | - |
University of Barcelona
| 28 years |
Juan-José López Burniol | M | 79 |
University of Barcelona
| - |
Manuel Reina | M | - |
University of Barcelona
| - |
Martin Welschof | M | 63 |
Uni Targeting Research AS
Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | 17 years |
Joaquín Maria Molins López-Rodó | M | 73 |
University of Barcelona
| - |
Elisenda Malaret García | F | 66 |
University of Barcelona
| 29 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Spain | 25 | 78.13% |
Norway | 7 | 21.88% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Albert Tauler
- Personal Network